SCHEMBL715236

SCHEMBL715236

CC(=O)Oc1ccc(CCc2cccc(OC(C)=O)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
CYP3A4 P08684 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
ACHE P22303 5/20 0.50
PARP1 P09874 1/20 0.47
PTGS2 P35354 1/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
TTR P02766 1/20 0.46
TP53 P04637 1/20 0.46
KMT2A Q03164 1/20 0.46
ELANE P08246 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL715536 0.92 CYP3A4 (0.56) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL10149053 0.90 LMNA (0.60) LMNACYP3A4ACHEPARP1MAPT
SCHEMBL10183475 0.87 CYP3A4 (0.60) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL13252495 0.87 LMNA (0.60) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL717987 0.86 NPC1 (0.65) LMNASMN1; SMN2NPC1RAB9APTGS2
SCHEMBL718523 0.86 MAPT (0.56) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL9081470 0.86 LMNA (0.61) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL1561685 0.85 CYP3A4 (0.56) LMNACYP3A4ACHEPARP1PTGS2
SCHEMBL21225979 0.85 ALOX5 (0.57) LMNACYP3A4ACHEPARP1MTNR1A
SCHEMBL13314605 0.83 ALDH1A1 (0.55) LMNACYP3A4SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 US disclosed
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed
EP-2391658-A1 MOLECULARLY IMPRINTED POLYMERS Commonwealth Scientific and Industrial Research Organisation (AU) 2011-12-07 EP disclosed
WO-2010085851-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-08-05 WO disclosed
WO-2010085851-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 LMNA 3479/4885CYP3A4 780/4885SMN1; SMN2 3871/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 LMNA 3479/4885CYP3A4 780/4885SMN1; SMN2 3871/4885
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 LMNA 3479/4885CYP3A4 780/4885SMN1; SMN2 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.